These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 35275259)
21. [A rare case of intraductal tumor of the pancreas in which an intraductal tubulopapillary neoplasm was mixed with a widely spreading gastric-type intraductal papillary-mucinous neoplasm]. Wakabayashi T; Shirota Y; Takeda Y; Hodo Y; Ueda Y Nihon Shokakibyo Gakkai Zasshi; 2024; 121(5):415-424. PubMed ID: 38735750 [TBL] [Abstract][Full Text] [Related]
22. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768 [TBL] [Abstract][Full Text] [Related]
23. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up. Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561 [TBL] [Abstract][Full Text] [Related]
24. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines]. Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626 [No Abstract] [Full Text] [Related]
25. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus. Tanaka M Digestion; 2014; 90(4):265-72. PubMed ID: 25591885 [TBL] [Abstract][Full Text] [Related]
26. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study. Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906 [TBL] [Abstract][Full Text] [Related]
27. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706 [TBL] [Abstract][Full Text] [Related]
28. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. Kanno A; Satoh K; Hirota M; Hamada S; Umino J; Itoh H; Masamune A; Asakura T; Shimosegawa T J Gastroenterol; 2010 Sep; 45(9):952-9. PubMed ID: 20383536 [TBL] [Abstract][Full Text] [Related]
29. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm. Lee KH; Lee SJ; Lee JK; Ryu JK; Kim EY; Kim TH; Moon JH; Lee WJ; Cho YK; Kim JJ Pancreas; 2014 Nov; 43(8):1306-11. PubMed ID: 25036913 [TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging-derived fat fraction predicts risk of malignancy in intraductal papillary mucinous neoplasm. Evrimler S; Yip-Schneider MT; Swensson J; Soufi M; Muraru R; Tirkes T; Schmidt CM; Akisik F Abdom Radiol (NY); 2021 Oct; 46(10):4779-4786. PubMed ID: 34086091 [TBL] [Abstract][Full Text] [Related]
31. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline. Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876 [TBL] [Abstract][Full Text] [Related]
33. Carbohydrate Antigen 19-9 Is an Invasive Malignancy Preoperative Prognostic Factor for Intraductal Papillary Mucinous Neoplasms. Suzuki S; Shimoda M; Shimazaki J; Oshiro Y; Nishda K; Orimoto N; Nagakawa Y; Tsuchida A Eur Surg Res; 2021; 62(4):262-270. PubMed ID: 34344012 [TBL] [Abstract][Full Text] [Related]
34. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery. Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130 [TBL] [Abstract][Full Text] [Related]
39. CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms. Kim MC; Kim JH; Jeon SK; Kang HJ PLoS One; 2024; 19(4):e0298278. PubMed ID: 38683769 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]